Dachser, made a resounding mark at LogiPharma Boston 2023 by unveiling its dedicated service portfolio tailored for the life science and healthcare industry. This is Following a successful presence at LogiPharma in Lyon, France earlier this year, Dachser demonstrated its prowess in this sector to a discerning audience in the United States.
Under the resounding banner, “We care for healthcare. Around the globe,” the Business Field Solution Life Science and Healthcare Logistics took center stage at the LogiPharma Boston fair held from October 4 to October 6, 2023. This premier event is renowned as the world’s leading trade fair for pharmaceutical supply chain executives, This offered a prime platform for Dachser to showcase its industry-leading capabilities.
Dachser’s Business Field Solution, Life Science and Healthcare Logistics, offers a comprehensive range of standardized and specialized logistics services tailored to the unique demands of the life science and healthcare industry. These services span the entire healthcare chain and cover a spectrum of temperature ranges, ensuring the highest levels of flexibility and reliability. Augmented by a team of expert professionals specializing in life science and healthcare, Dachser fosters close, partnership-based relationships with its customers across the globe.
Netka Hohlfeld, Department Head of Life Science and Healthcare Logistics at Dachser, emphasized the significance of LogiPharma Boston for the company, stating, “Next to Asia and Europe, the Americas are another region in the Dachser network where the demanding requirements of our life science and healthcare customers can be fully satisfied. The transport of products from this industry segment has to meet high standards. Medicines and other pharmaceutical products are often temperature-sensitive, and urgent shipments have to be handled in compliance with a complex regulatory environment.”
In an era where digital supply chains with impeccable visibility are paramount, Dachser’s LSH Logistics experts excel in understanding the specific challenges and requirements of their customers. They offer a holistic range of patient-oriented, forward-looking, and intelligent transport solutions. Moreover, Dachser’s unique amalgamation of swift air freight transportation and distribution through its extensive European road transport network presents a distinct advantage for customers in the life science and healthcare sector.
Highlighting Dachser’s unwavering commitment to quality, the Good Distribution Practice (GDP) compliance certification serves as a testament to the impeccable standards adhered to within Dachser’s life science and healthcare network. This certification, awarded by an external certification body, attests to Dachser’s compliance with rigorous quality criteria in this business field, ensuring shipments meet EU regulations.
With 2024 on the horizon, Dachser anticipates further certifications for locations in the Americas and APAC regions, solidifying its position as a frontrunner in the global healthcare logistics landscape.
